EMA Authorised: Betaferon (interferon beta-1b) — Bayer AG

View source ↗

Summary

EMA authorised Betaferon (interferon beta-1b) by Bayer AG for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis. MAH: Bayer AG. Decision date: 23/11/2023